Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRI in CIS and relapsing multiple sclerosis after single vs cumulative dose of Gadovist at 3.0T
2009-016140-39Phase 4Active
- Sponsor
- Institut de Diagnòstic per la Imatge
- Start
- Oct 2009
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of gadobutrol in clinically isolated syndrome (CIS) and multiple sclerosis (MS), sponsored by Institut de Diagnòstic per la Imatge. Primary endpoint: Number of gadolinium-enhancing lesions. Started Oct 2009; status: active.
02
Drugs
gadobutrol
03
Conditions
clinically isolated syndrome (CIS)multiple sclerosis (MS)
Beyond the preview
Go deeper on 2009-016140-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016140-39.